MOORESVILLE — Two people died Sunday night following a crash during a police pursuit in Hendricks County that began in Mooresville, according to police.
Officers with the Mooresville Metropolitan Police Department attempted to stop a 41-year-old man driving an orange Honda Element around 9:37 p.m. in the area of southbound State Road 67 and Woodside Drive.
A news release provided by Mooresville Police said the driver initially stopped but did a U-turn on SR 67 when officers approached and drove away northbound at a high rate of speed.
The driver continued driving into Hendricks County where he ran a red light at the intersection of SR 67 and Enterprise Drive near Heartland Crossing and crashed into a black Mazda driven by a 62-year-old woman.
Both vehicles caught fire after they came to rest in the median of SR 67, according to Mooresville Police.
Medics transported the drivers of both vehicles to Eskenazi Hospital where they later died. Their identities have not been publicly released.
No other injuries were reported.
The pursuit and crash remain under investigation.
Anyone with videos, photos or information about the crash are asked to contact the Mooresville Metropolitan Police Department dispatch center at 317-831-3434.
-
Gun rights, sports bans, tariffs — key Supreme Court rulings on the horizon
From tariffs to gun rights to sports bans, the U.S. Supreme Court’s decisions this term could reshape interpretations of the Constitution on personal rights and presidential power.
Zedd returns to headline 2026 Indy 500 Snake Pit
Electronic superstar Zedd is coming back to Indianapolis Motor Speedway, set to headline the 2026 Indy 500 Coors Light Snake Pit.
Bill that could bring Chicago Bears to Indiana advances in House committee
The Chicago Bears moved closer to relocating to Indiana Thursday as a House committee unanimously passed legislation creating the framework to finance a new NFL stadium in Hammond.
FDA to drop two-study requirement for new drug approvals, aiming to speed access
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs.
